PureTech Health PLC (NAS:PRTC)
$ 24.53 -1.37 (-5.29%) Market Cap: 598.64 Mil Enterprise Value: 330.27 Mil PE Ratio: 0 PB Ratio: 1.34 GF Score: 53/100

PureTech Health PLC at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 14, 2021 / 03:50PM GMT
Release Date Price: $54 (-2.00%)
Unidentified Analyst

Good morning, everyone, and welcome to the 39th Annual JPMorgan Healthcare Conference. My name is [Vedder Schader]. I'm a Vice President in our health care investment banking team. And it's my pleasure today to introduce you to our next presenting company, that is PureTech. And we have our next presenter, Daphne Zohar, the founder and CEO of PureTech.

Before we start, though, I'd just like to mention that we'll -- after the prepared remarks, we'll have about 10 to 15 minutes of Q&A, and you'll be able to submit a question through the link on the website, the blue Submit A Question button.

And with that, I'll hand it over to Daphne.

Daphne Zohar
PureTech Health plc - Founder, CEO & Executive Director

Thank you, [Vedder], and to the JPMorgan team for inviting us to present, and welcome to everyone who is listening and watching via webcast.

We have a very unique story to tell at PureTech. And importantly, we have a highly promising wholly-owned therapeutic development pipeline that we're going to dig into during

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot